{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:02:20Z","timestamp":1790337740431,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000837","name":"University of Nottingham","doi-asserted-by":"publisher","award":["ESR11"],"award-info":[{"award-number":["ESR11"]}],"id":[{"id":"10.13039\/501100000837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010757","name":"National Centre for the Replacement Refinement and Reduction of Animals in Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011097","name":"CARIM School for Cardiovascular Diseases, Universiteit Maastricht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001835","name":"Universiteit Maastricht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022416","name":"Center for Drug Evaluation and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004528","name":"Maastricht Universitair Medisch Centrum","doi-asserted-by":"publisher","award":["ESR15"],"award-info":[{"award-number":["ESR15"]}],"id":[{"id":"10.13039\/501100004528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012950","name":"Institut national de recherche en informatique et en automatique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["858070"],"award-info":[{"award-number":["858070"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vascn.2026.108433","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:43:46Z","timestamp":1781279026000},"page":"108433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The INSPIRE doctoral network in safety pharmacology \u2013 Looking back and ahead"],"prefix":"10.1016","volume":"140","author":[{"given":"Pieter-Jan","family":"Guns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta Rita","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Cherubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Hlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham Ataei","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Costa-Faya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Henri","family":"Van Assche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callan D.","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benji","family":"Van Berlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin Nicolas","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Savchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido R.Y.","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2026.108433_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107296","article-title":"Optimization of bioanalysis of dried blood samples","volume":"123","author":"Alizadeh","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108433_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107764","article-title":"Implementation of automated blood sampling in a canine cardiovascular safety pharmacology study to support PK\/PD assessment","volume":"135","author":"Alizadeh","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108433_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107263","article-title":"The impact of environmental and biological factors on the resting heart rate of dogs as assessed using 20 years of data from safety pharmacology studies","volume":"121","author":"Alizadeh","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1","key":"10.1016\/j.vascn.2026.108433_bb0020","article-title":"Group social dynamics in a seminatural setup reflect the adaptive value of aggression in male mice","volume":"5","author":"Anpilov","year":"2025","journal-title":"Biological Psychiatry: Global Open Science"},{"key":"10.1016\/j.vascn.2026.108433_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12688\/openreseurope.13094.2","article-title":"Doctoral studies as part of an innovative training network (ITN): Early stage researcher (ESR) experiences","volume":"1","author":"Biswas","year":"2021","journal-title":"Open Research Europe"},{"issue":"15","key":"10.1016\/j.vascn.2026.108433_bb0030","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1093\/cvr\/cvad136","article-title":"Doxorubicin-induced cardiovascular toxicity: A longitudinal evaluation of functional and molecular markers","volume":"119","author":"Bosman","year":"2023","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2026.108433_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1584734","article-title":"Bridging the gaps in detection of structural cardiotoxicity in stem cell-derived cardiomyocytes: Promise of miR-133b, miR-184 and miR-208b-3p","volume":"16","author":"Cherubin","year":"2025","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2026.108433_bb0040","author":"Comission, E.-E"},{"issue":"1","key":"10.1016\/j.vascn.2026.108433_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54908-5","article-title":"Small-molecule-induced ERBB4 activation to treat heart failure","volume":"16","author":"Cools","year":"2025","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.vascn.2026.108433_bb0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s13239-025-00796-9","article-title":"Validation of a mathematical model of Arterial Wall mechanics with drug induced vasoconstriction against ex vivo measurements","volume":"16","author":"Costa Faya","year":"2025","journal-title":"Cardiovascular Engineering and Technology"},{"key":"10.1016\/j.vascn.2026.108433_bb0055","author":"FDA"},{"issue":"3","key":"10.1016\/j.vascn.2026.108433_bb0060","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00459.2024","article-title":"Quantitative interpretation and modeling of continuous nonprotein respiratory quotients","volume":"328","author":"Gan","year":"2025","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.vascn.2026.108433_bb0065","author":"GOV.UK"},{"key":"10.1016\/j.vascn.2026.108433_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106889","article-title":"INSPIRE: A European training network to foster research and training in cardiovascular safety pharmacology","volume":"105","author":"Guns","year":"2020","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108433_bib161","series-title":"S7A safety pharmacology studies for human pharmaceuticals","year":"2001"},{"key":"10.1016\/j.vascn.2026.108433_bib162","series-title":"S7B the nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals","year":"2005"},{"key":"10.1016\/j.vascn.2026.108433_bib163","series-title":"S9 nonclinical evaluation for anticancer pharmaceuticals","year":"2009"},{"key":"10.1016\/j.vascn.2026.108433_bb0075","article-title":"Measuring locomotor activity and behavioral aspects of rodents living in the home-cage","volume":"16","author":"Klein","year":"2022","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"1","key":"10.1016\/j.vascn.2026.108433_bb0080","first-page":"40","article-title":"Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice","volume":"10","author":"Kr\u00fcger","year":"2024","journal-title":"Cardiooncology"},{"issue":"1","key":"10.1016\/j.vascn.2026.108433_bb0085","first-page":"65","article-title":"Dexrazoxane prevents vascular toxicity in doxorubicin-treated mice","volume":"10","author":"Kr\u00fcger","year":"2024","journal-title":"Cardiooncology"},{"issue":"1","key":"10.1016\/j.vascn.2026.108433_bb0090","first-page":"14","article-title":"Acute vascular and cardiac effects of lenvatinib in mice","volume":"11","author":"Kr\u00fcger","year":"2025","journal-title":"Cardiooncology"},{"issue":"14","key":"10.1016\/j.vascn.2026.108433_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5120\/ijca2022922119","article-title":"Artificial neural network comparison on hERG channel blockade detection","volume":"184","author":"Liu","year":"2022","journal-title":"International Journal of Computer Applications"},{"key":"10.1016\/j.vascn.2026.108433_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105904","article-title":"A call to action: Advancing new approach methodologies (NAMs) in regulatory toxicology through a unified framework for validation and acceptance","volume":"162","author":"Ouedraogo","year":"2025","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"6","key":"10.1016\/j.vascn.2026.108433_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065374","article-title":"COVID-19-induced myocarditis: Pathophysiological roles of ACE2 and toll-like receptors","volume":"24","author":"Pannucci","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.vascn.2026.108433_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.116007","article-title":"Role of endothelin ET(A) receptors in the hypertension induced by the VEGFR-2 kinase inhibitors axitinib and lenvatinib in conscious freely-moving rats","volume":"228","author":"Pannucci","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.vascn.2026.108433_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1644119","article-title":"Integral approach to organelle profiling in human iPSC-derived cardiomyocytes enhances in vitro cardiac safety classification of known cardiotoxic compounds","volume":"7","author":"Szabo","year":"2025","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.vascn.2026.108433_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2026.106096","article-title":"Revisiting ICH S7A after 25 years: Outcomes of a multi-stakeholder workshop and strategic pillars for modernizing safety pharmacology","volume":"169","author":"Valentin","year":"2026","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2026.108433_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2025.107763","article-title":"Results from an EFPIA, JPMA, PhRMA industry survey on reopening and revamping the ICH S7A guidance on safety and secondary pharmacology","volume":"135","author":"Valentin","year":"2025","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108433_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107269","article-title":"\u201cAppraisal of state-of-the-art\u201d the 2021 distinguished service award of the safety pharmacology society: Reflecting on the past to tackle challenges ahead","volume":"123","author":"Valentin","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108433_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.125667","article-title":"Improved on-tissue detection of the anti-cancer agent doxorubicin by quantitative matrix-assisted laser desorption\/ionization mass spectrometry imaging","volume":"271","author":"Van Assche","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.vascn.2026.108433_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/20480040221092893","article-title":"Monitoring haemodynamic changes in rodent models to better inform safety pharmacology: Novel insights from in vivo studies and waveform analysis","volume":"11","author":"Van Daele","year":"2022","journal-title":"JRSM Cardiovascular Disease"},{"key":"10.1016\/j.vascn.2026.108433_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115672","article-title":"Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanoBRET","volume":"214","author":"Van Daele","year":"2023","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2026.108433_bb0150","doi-asserted-by":"crossref","first-page":"18337","DOI":"10.1038\/s41598-024-68725-9","article-title":"Unravelling the impact of active and passive contributors to arterial stiffness in male mice and their role in vascular aging","volume":"14","author":"Wesley","year":"2024","journal-title":"Scientific Reports"},{"issue":"10","key":"10.1016\/j.vascn.2026.108433_bb0155","article-title":"Short-term proteasome inhibition: Assessment of the effects of carfilzomib and bortezomib on cardiac function, arterial stiffness, and vascular reactivity","volume":"13","author":"Wesley","year":"2024","journal-title":"Biology-Basel"},{"issue":"3","key":"10.1016\/j.vascn.2026.108433_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeaf021","article-title":"Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: Evidence from a nationwide nested case-control study paralleled with matched experimental models","volume":"5","author":"Wesley","year":"2025","journal-title":"European Heart Journal Open"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:22:05Z","timestamp":1790335325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871926000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S1056871926000262"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108433","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The INSPIRE doctoral network in safety pharmacology \u2013 Looking back and ahead","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108433"}}